Dergiler / Epilepsi / 2021 / Cilt: 27 - Sayı: 4

Epileptic Seizures Observed in Hospitalized COVID-19 Patients

Sayfa
221–225
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: COVID-19 infection can increase the likelihood of seizures like other viral infections, but we do not have strong data that it can trigger seizures in different ways compared to other viral agents with all the data.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Pneumonia cases that first started in Wuhan were defined as Severe Acute Respiratory Syndrome Coronavirus-2 by The World Health Organization in January 2020.
📊
Temel Bulgular & Veri:Neurological complications such as epileptic seizures may occur during COVID-19 infection.
💡
Sonuç & Katkı:Conclusion: COVID-19 infection can increase the likelihood of seizures like other viral infections, but we do not have strong data that it can trigger seizures in different ways compared to other viral agents with all the data.
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: Pneumonia cases that first started in Wuhan were defined as Severe Acute Respiratory Syndrome Coronavirus-2 by The World Health Organization in January 2020. Neurological complications such as epileptic seizures may occur during COVID-19 infection. These seizures may occur for the first time or in the form of acute seizures that can be observed in epilepsy patients during the course of the disease. Methods: Demographic data of the patients, presence of the diagnosis of epilepsy disease, accompanying diseases, number of seizures during hospitalization, follow-up to the intensive care unit, COVID-19 clinical day during seizures, presence of disease that can be detected in the etiology of epilepsy, and discharge status were examined in this retrospectively planned study. Results: Seizure rate was determined to be 0.57% in these patients. 18 (58.1%) patients did not have a history of epilepsy, whereas 13 (41.9%) patients had a history of epilepsy. It was found that mortality was higher in the first seizures; there was no difference between age, gender, COVID-19 clinical day, presence of hospitalization in the intensive care unit, and Modified Charlson Comorbidity Index when the data of patients with and without epilepsy were compared. Conclusion: COVID-19 infection can increase the likelihood of seizures like other viral infections, but we do not have strong data that it can trigger seizures in different ways compared to other viral agents with all the data.

🔖

Bu Makaleye Atıf Yap

USTA, N. C. (2022). Epileptic Seizures Observed in Hospitalized COVID-19 Patients. Epilepsi, Cilt: 27 - Sayı: 4, 221–225. https://ajindex.com/articles/501617

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91(1):157–60
  2. Josephson SA, Kamel H. Neurology and COVID-19. JAMA 2020;324(12):1139–40
  3. Nikbakht F, Mohammadkhanizadeh A, Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Mult Scler Relat Disord 2020;46:102535
  4. Steardo L, Steardo L Jr., Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) 2020;229(3):e13473
  5. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):683–90
  6. Vohora D, Jain S, Tripathi M, Potschka H. COVID-19 and seizures: Is there a link? Epilepsia 2020;61(9):1840–53
  7. Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: A systematic review and current update. Acta Neurol Scand 2020;142(1):14–22
  8. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55–8
  9. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020;7(1):4
  10. Brusselaers N, Lagergren J. The charlson comorbidity index in registry-based research. Methods Inf Med 2017;56(5):401–6. 11. van den Pol AN. Viral infections in the developing and mature brain. Trends Neurosci 2006;29(7):398–406
  11. Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study. Epilepsia 2020;61(6):e49–53
  12. Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Ray BK. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci 2021;48(1):9–24
  13. Chen W, Toprani S, Werbaneth K, Falco-Walter J. Status epilepticus and other EEG findings in patients with COVID-19: A case series. Seizure 2020;81:198–200
  14. Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, et al. Focal status epilepticus as unique clinical feature of COVID-19: A case report. Seizure 2020;78:109–12
  15. Feyissa AM, Hasan TF, Meschia JF. Stroke-related epilepsy. Eur J Neurol 2019;26(1):18–e3
  16. Trejo-Gabriel-Galán JM. Stroke as a complication and prognostic factor of COVID-19. Neu